Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.69B |
| 2 |
Abbott
ABT
|
+$3.65B |
| 3 |
Qualcomm
QCOM
|
+$3.54B |
| 4 |
Procter & Gamble
PG
|
+$3.42B |
| 5 |
Accenture
ACN
|
+$3.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.86B |
| 2 |
AbbVie
ABBV
|
+$2.71B |
| 3 |
Valero Energy
VLO
|
+$1.86B |
| 4 |
Lockheed Martin
LMT
|
+$916M |
| 5 |
Halliburton
HAL
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 10.68% |
| 3 | Healthcare | 10.19% |
| 4 | Industrials | 8.63% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRMM
3301
Forum Markets
FRMM
$75.7M
| $199K | ﹤0.01% |
69,000
+550
| +0.8% | +$2.1K |
|
3302
Clarus
CLAR
$125M
| $198K | ﹤0.01% |
72,689
-12,034
| -14% | -$39.5K |
|
|
SUNS
3303
Sunrise Realty Trust
SUNS
$108M
| $197K | ﹤0.01% |
25,744
-2,343
| -8% | -$21.3K |
|
3304
Immuneering
IMRX
$279M
| $197K | ﹤0.01% |
37,344
+15,000
| +67% | +$76.9K |
|
|
AVBC
3305
Avidia Bancorp
AVBC
$400M
| $197K | ﹤0.01% |
10,000
| – | – |
|
|
SUIG
3306
Sui Group Holdings
SUIG
$80.1M
| $195K | ﹤0.01% |
160,791
+1,210
| +0.8% | +$1.79K |
|
3307
Purple Innovation
PRPL
$33.2M
| $190K | ﹤0.01% |
11,480
+123
| +1% | +$2.15K |
|
|
XMAX
3308
XMAX Inc
XMAX
$536M
| $188K | ﹤0.01% |
+26,000
| New | +$161K |
|
|
MPX
3309
DELISTED
Marine Products Corp
MPX
| $187K | ﹤0.01% |
25,735
-25
| -0.1% | -$206 |
|
3310
Minerva Neurosciences
NERV
$188M
| $187K | ﹤0.01% |
+31,000
| New | +$178K |
|
3311
Zura Bio
ZURA
$497M
| $185K | ﹤0.01% |
+31,096
| New | +$188K |
|
3312
Consumer Portfolio Services
CPSS
$205M
| $185K | ﹤0.01% |
23,930
-4,169
| -15% | -$34.8K |
|
3313
Century Therapeutics
IPSC
$381M
| $179K | ﹤0.01% |
+79,415
| New | +$167K |
|
|
APC
3314
ARKO Petroleum
APC
$991M
| $179K | ﹤0.01% |
+10,000
| New | +$185K |
|
3315
Arq
ARQ
$86.9M
| $179K | ﹤0.01% |
69,775
-30,218
| -30% | -$96.8K |
|
|
HURA
3316
TuHURA Biosciences
HURA
$134M
| $177K | ﹤0.01% |
98,937
+17,017
| +21% | +$20.9K |
|
3317
Rhinebeck Bancorp
RBKB
$194M
| $175K | ﹤0.01% |
11,327
| – | – |
|
|
FWDI
3318
Forward Industries Inc
FWDI
$287M
| $173K | ﹤0.01% |
39,052
| – | – |
|
3319
Comstock
LODE
$228M
| $172K | ﹤0.01% |
56,249
| – | – |
|
3320
Avita Medical
RCEL
$142M
| $171K | ﹤0.01% |
46,306
+51
| +0.1% | +$214 |
|
3321
1stdibs.com
DIBS
$145M
| $170K | ﹤0.01% |
30,992
-92
| -0.3% | -$510 |
|
3322
CSP Inc
CSPI
$80.1M
| $166K | ﹤0.01% |
19,242
-3,845
| -17% | -$38.2K |
|
|
ATYR
3323
aTyr Pharma
ATYR
$46.4M
| $164K | ﹤0.01% |
210,737
-11,030
| -5% | -$9.31K |
|
3324
Ovid Therapeutics
OVID
$435M
| $160K | ﹤0.01% |
+72,000
| New | +$129K |
|
|
IRD
3325
Opus Genetics
IRD
$254M
| $159K | ﹤0.01% |
+35,000
| New | +$121K |
|
Similar funds
Charles Schwab's Q1 2026 Portfolio in Review
As of Q1 2026, Charles Schwab held 3,535 positions worth $654B, up 1.7% from $644B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab deployed $21.4B of net new capital in Q1 2026, opening 79 new positions and adding to 1,903 existing holdings. Its largest new stake was JPMorgan Income ETF: 8,679,689 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $2.86B trimmed.
- Charles Schwab's largest Q1 2026 buy was JPMorgan Income ETF: 8,679,689 shares worth $400M.
- Charles Schwab added most to UnitedHealth in Q1 2026, an estimated $3.69B increase.
- Charles Schwab's biggest Q1 2026 reduction was Cisco, cutting an estimated $2.86B.
- Charles Schwab fully exited Comerica in Q1 2026, selling an estimated $412M.
- Charles Schwab's ten largest holdings make up 22% of its $654B portfolio in Q1 2026.
- Charles Schwab opened 79 new positions and closed 80 in Q1 2026.
- Charles Schwab's portfolio value rose 1.7% quarter-over-quarter to $654B.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.